论文部分内容阅读
自从1965年Blumberg等发现Au抗原以来,对输血后肝炎的预防有了很大进展。但其发病率仍超过15%,其中少数为乙型肝炎,多数为非甲非乙型肝炎。如何预防至今未解决。普及应用血液成分制剂以来,其发病率仍有增加之势。一、判定标准和发生率输血后肝炎的诊断标准,日本统一采用在输血后l～2周观察一次肝功能,在3周至6个月内GPT值连续2次高于50U为可疑;超过200U或100～200U
Since the discovery of the Au antigen by Blumberg et al. In 1965, great advances have been made in the prevention of post-transfusion hepatitis. However, its incidence is still over 15%, a small number of which is hepatitis B, most of which are non-A, non-B hepatitis. How to prevent so far not resolved. Since the popularity of blood component preparations, the incidence rate is still increasing. First, determine the standard and incidence of post-transfusion hepatitis diagnostic criteria, the Japanese unified use of blood transfusion 1 to 2 weeks to observe a liver function, GPT values within 3 weeks to 6 months 2 times higher than 50U suspicious; more than 200U or 100 ~ 200U